tetano
Editor, Senior Moderator
Cureus
. 2021 Nov 4;13(11):e19258.
doi: 10.7759/cureus.19258. eCollection 2021 Nov.
Non-ST Segment Elevation Myocardial Infarction Secondary to Coronary Multi-Vessel Thrombosis in the Setting of COVID-19
Aishwarya Sharma[SUP] 1 [/SUP], Abhishek Matta[SUP] 2 3 [/SUP], Danielle Matta[SUP] 4 [/SUP], Dinesh Bande[SUP] 3 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) has been shown to impact the cardiovascular system by causing congestive heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), or nonischemic cardiomyopathy. The infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggers the overproduction of proinflammatory cytokines, generating systemic inflammation and a procoagulant state that can lead to cardiovascular morbidity and mortality. Symptomatology may not be discrete with presentation of chest pain, dyspnea, and fatigue, so careful consideration should be applied to cardiovascular complications. Serial troponin dosage as well as EKG changes serve as viable prognosis markers. Prompt dissolution of the thrombi will minimize the extent of the myocardial injury.
Keywords: acute coronary syndrome; covid 19; multiple thrombi; non-st segment elevation myocardial infarction (nstemi); sars-cov-2 infection.
. 2021 Nov 4;13(11):e19258.
doi: 10.7759/cureus.19258. eCollection 2021 Nov.
Non-ST Segment Elevation Myocardial Infarction Secondary to Coronary Multi-Vessel Thrombosis in the Setting of COVID-19
Aishwarya Sharma[SUP] 1 [/SUP], Abhishek Matta[SUP] 2 3 [/SUP], Danielle Matta[SUP] 4 [/SUP], Dinesh Bande[SUP] 3 [/SUP]
Affiliations
- PMID: 34881121
- PMCID: PMC8643244
- DOI: 10.7759/cureus.19258
Abstract
Coronavirus disease 2019 (COVID-19) has been shown to impact the cardiovascular system by causing congestive heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), or nonischemic cardiomyopathy. The infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggers the overproduction of proinflammatory cytokines, generating systemic inflammation and a procoagulant state that can lead to cardiovascular morbidity and mortality. Symptomatology may not be discrete with presentation of chest pain, dyspnea, and fatigue, so careful consideration should be applied to cardiovascular complications. Serial troponin dosage as well as EKG changes serve as viable prognosis markers. Prompt dissolution of the thrombi will minimize the extent of the myocardial injury.
Keywords: acute coronary syndrome; covid 19; multiple thrombi; non-st segment elevation myocardial infarction (nstemi); sars-cov-2 infection.